Article Text

Download PDFPDF
A bedside prediction tool predicted all cause mortality 6 months after discharge for acute coronary syndrome

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.


 
 Q In patients hospitalised for acute coronary syndrome (ACS), does a bedside prediction tool predict all cause mortality?

Clinical impact ratings GP/FP/Primary care ★★★★★☆☆ Internal medicine ★★★★★☆☆ Cardiology ★★★★★☆☆

METHODS

Embedded ImageDesign:

2 cohort studies, 1 for derivation and 1 for validation (Global Registry of Acute Coronary Events [GRACE]).

Embedded ImageSetting:

94 hospitals in 14 countries.

Embedded ImagePatients:

patients who were ⩾18 years of age, alive at discharge, and hospitalised for presumed ACS and had ⩾1 of electrocardiographic changes consistent with ACS, serial increases in serum cardiac biomarkers, or confirmed coronary artery disease. The qualifying ACS must not have been precipitated by non-cardiovascular comorbid conditions. At discharge, patients were assigned to ST segment elevation myocardial infarction (STEMI), non-ST segment elevation myocardial infarction (NSTEMI), or unstable angina categories. 15 007 patients formed the derivation cohort and …

View Full Text

Footnotes

  • For correspondence: Dr K A Eagle, University of Michigan Health System, Ann Arbor, MI, USA. keagleumich.edu

  • Source of funding: Aventis Pharma.